reported on the use of titanium cervical cages in the treatment of sagittal plane deformities. In their study of 66 patients whose mean follow-up period was 33 months, a fusion rate of 78% was observed, although the authors pointed out the difficulty of assessing fusion radiographically in the setting of a metal implant.
The history of bioabsorbable implants for human application began with absorbable sutures. Today these materials are commonly used for a variety of reconstructive purposes. Orthopedic surgeons routinely use bioabsorbable interference screws in anterior cruciate ligament and arthroscopic shoulder repairs. Resorbable products are also enjoying popularity in fracture fixation. [3] [4] [5] 11 A bioabsorbable interbody spacer has many potential advantages compared with contemporary metallic implants. First, bioabsorbable devices allow for a much improved radiographic assessment due to their radiolucency. Another drawback of rigid metallic devices is the mismatch in their modulus of elasticity compared with vertebral bone, which yields the potential for stress shielding and subsidence. By comparison, bioabsorbable implants degrade over time, resulting in gradual dynamization Neurosurg Focus 16 (3): Article 7, 2004 , Click here to return to Table of Contents Early findings in a pilot study of anterior cervical fusion in which bioabsorbable interbody spacers were used across the implant, graft, and vertebral bone, possibly improving the likelihood of successful fusion. In addition, bioabsorbable implants may be capable of serving as carriers for growth factors such as bone morphogenetic proteins without the need for adjunctive internal fixation. 8 This study is an early retrospective evaluation of an anterior cervical interbody spacer used in the treatment of symptomatic cervical degenerative disease.
CLINICAL MATERIAL AND METHODS

Patient Population
A retrospective chart and radiographic review was conducted in the first eight consecutive patients who underwent an anterior cervical decompression and fusion in which a bioabsorbable interbody spacer and anterior cervical metallic plate were used. These patients were treated for symptomatic cervical disc degeneration by a single surgeon (W.S.) between February and March 2003. There were five women and three men with a mean age of 52 and an age range of 46 to 64 years. The diagnoses were radiculopathy in one patient, myelopathy in three, and a combination of radiculopathy and myelopathy in the other four. Patients were given the option of surgical intervention if they failed to improve after conservative treatment consisting of initial rest and immobilization, nonsteroidal antiinflammatory medications, and physical therapy in the setting of objective anterior thecal sac or nerve root compression on magnetic resonance imaging.
Surgical Procedure
Two patients underwent a single-level, three a twolevel, two a three-level, and one a four-level anterior cervical discectomy and fusion with a Cornerstone HSR (Medtronic Sofamor Danek, Memphis, TN) bioabsorbable spacer (Fig. 1 ) via a standard left-sided anterior Smith-Robinson approach, followed by anterior metallic plate application. One patient (Case 4) also underwent an adjunctive posterior cervical fusion with lateral mass instrumentation for multilevel cervical stenosis in the setting of symptomatic cervical myelopathy. All patients were treated with adjunctive anterior cervical titanium plate fixation. The interbody spacers or cages were made of a resorbable poly-lactide, that is, 70:30 poly(L-lactide-co-D,L-lactide), which naturally degrades to carbon dioxide and water. The implants are available in two primary configurations (14-mm width ϫ 11-mm depth and 11-mm width ϫ 11-mm depth), and in heights ranging from 5 through 10 mm in 1-mm increments.
An independent retrospective chart review was performed to gather pertinent patient data including age, sex, duration of symptoms, physical examination findings, types of conservative treatments, surgical approach, level of fusion, use of allograft or autograft bone, use of bone graft extenders or replacements, and use of adjunctive internal fixation as well as length of follow up, smoking history, and patient involvement in either litigation or Worker's compensation claims. Additionally, information was gathered on any postoperative complications, including difficulty swallowing, hoarseness, neck pain, bone graft site discomfort, infection, or hematoma. Imaging studies, including plain x-ray films and computerized tomography scans when available, were reviewed to assess fusion healing or abnormal soft tissue reactions.
Fusion was characterized by a lack of motion between spinous processes on flexion/extension radiographs; absence of a radiolucent space between the graft, interbody spacers (cages), and vertebral endplates; and the presence of bridging by bone trabeculae at the graft/host vertebral endplate interface. Pseudarthrosis was defined as obvious motion between the spinous processes as seen on flexion/extension radiographs, a lucent line at the graft/vertebral endplate boundary, and a lack of osseous trabecular bridging between the graft and host vertebral endplates. Soft tissue changes in the prevertebral space were measured as demonstrated in an illustrative case by using a horizontal line on a lateral plain x-ray film drawn from the anterior margin of the midintervertebral disc level to the posterior esophageal shadow prior to fusion and after cornerstone graft and anterior cervical plate placement (Fig. 2) .
To assess the clinical outcome of patients postoperatively, the criteria of Odom, et al., 10 were used. This scale involves dividing outcomes into four groups, as follows. 1) A poor outcome was defined as the presence of symptoms that were worse or with no improvement after surgical treatment. 2) A patient with symptomatic improvement but persistent physical limitations was designated as having a fair outcome. 3) A good outcome was characterized as the presence of sporadic symptoms that did not limit daily activities. 4) A patient with no symptoms and no limitations in activity was considered to have attained an excellent outcome. Table 1 , eight patients underwent an anterior cervical decompression and fusion in which a bioabsorbable anterior cervical interbody spacer and an anterior metallic cervical plate were used. The levels of fusion involved the C2-5 interspaces, the C3-4 interspace, the C3-6 interspaces, the C3-7 interspaces, and the C6-7 interspace in one patient each, and the C5-7 interspaces in three patients. The patient in Case 5 also underwent a posterior C3-7 laminectomy and fusion with lateral mass segmental fixation. The interbody spacer was filled with Grafton demineralized bone matrix putty (Osteotech, Inc., Eatontown, NJ) in all patients except one (Case 5). In this patient, rhBMP-2 was used anteriorly to fill the four cages used in the interspaces between C-3 and C-7.
RESULTS
As shown in
Follow up ranged from 6 to 9 months, with a mean follow-up duration of 7 months. Fusion was attempted in 18 interspaces, and 17 (94%) were noted to be fused on the available imaging studies (plain x-ray films and computerized tomography scans) at the most recent follow-up visit. The one patient who did not demonstrate fusion healing (Case 1) continued to show no definitive ossification within the interbody spacer at her 8-month follow-up evaluation (Fig. 3) . This patient was subsequently noted to have a good result at her latest clinical follow-up visit.
The sequence of plain x-ray film evidence of fusion maturation consisted of initial blurring irregularity of the absorbable spacer/host bone interface, followed by a distinct column of ossification noted in the midportion of the spacer connecting the contiguous endplates of the fused levels (Figs. 4 and 5 ). This column of ossification was most pronounced in the patient in Case 5, in whom rhBMP-2 was placed within the interbody fusion cages (Fig. 6) . Measurements of soft tissue shadows anterior to the metallic cervical plate showed no significant increase in the patients in whom adequate studies were available. In one patient (Case 8) there was an asymmetrical increased soft tissue shadow anterior to the cervical plate at the level of the C-6 vertebral body, but this had no clinical significance (Fig. 7) . In this patient the cephalad soft tis-
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Bioabsorbable interbody spacers in anterior cervical fusion 3 Fig. 2 . Left: Drawing showing soft tissue changes in the prevertebral space were measured using a horizontal line drawn from the midintervertebral disk level on a lateral plain x-ray film to the border of the esophageal shadow prior to fusion and placement of Cornerstone graft. Right: Drawing showing how soft tissue changes in the prevertebral space were measured using a horizontal line drawn from the midintervertebral disc level on a lateral plain x-ray film to the border of the esophageal shadow after placement of Cornerstone graft and an anterior cervical plate. sue measurement at approximately C-5 was 14 mm, at the midplate level (C-6) 20 mm, and at the inferior plate level (C-7) 16 mm. One significant perioperative complication was noted in the patient in Case 7. This patient suffered a symptomatic anterior soft tissue hematoma, which was successfully debrided 1 week after surgical intervention. At their latest follow-up review, three patients were noted to have good clinical outcomes and five had excellent clinical outcomes based on the criteria of Odom, et al.
10
DISCUSSION
The evolution of biotechnology has enabled spine surgeons to improve fusion rates by the local administration of rhBMP-2 and to avoid or minimize morbidity related to bone graft harvesting by using synthetic or machined allograft implants. Bioabsorbable implants also provide the potential benefit of improved visualization of the fusion interface. Additionally, through the process of gradual implant resorption, the contained graft substrate can be progressively subjected to loading and can be stimulated to heal.
In this retrospective study we assessed the radiographic and functional outcome in patients who underwent surgical management with an absorbable interbody cage for symptomatic cervical disc degeneration that was causing radiculopathy, myelopathy, or both. In patients with bioabsorbable cages, radiographic and functional outcomes were similar to those reported in a series in which traditional autologous bone grafts were used. 2 Our study dem- Fig. 3 . Lateral plain x-ray film obtained at 8-month follow up demonstrating no obvious bone bridging between the contiguous endplates. Fig. 4 . Lateral plain x-ray film demonstrating early loss of a distinct host bone/interbody spacer interface that was replaced with an irregular blurry interface. Fig. 5 . Lateral plain x-ray film demonstrating a solid anterior fusion with obvious bridging bone (distinct ossified column) between contiguous endplates in a patient in whom a demineralized bone matrix was used as the bone graft replacement in the interbody cages. Fig. 6 . Lateral plain x-ray film demonstrating a solid anterior fusion with obvious bridging bone (distinct ossified column) between contiguous endplates in a patient in whom rhBMP-2 was added to the interbody cervical spacers. onstrated the ease of assessing the graft/host bone interface in determining fusion status. The byproducts of cage resorption appeared to have no deleterious effect on fusion success: seven (88%) of eight patients were found to be healed on radiographical studies. There were no cage-related complications, although one patient demonstrated an asymmetrical anterior soft tissue shadow, which appeared to have no clinical sequelae.
In this study we have demonstrated the safety of a bioabsorbable anterior cervical cage. At an early follow up, the implant maintained sagittal alignment and stability while allowing fusion to occur. Inflammatory responses to the components of the bioabsorbable spacers appeared not to be a problem with the current bioabsorbable formulation and application. An interesting observation in this study was the finding of an initial loss and replacement of a distinct host bone/interbody spacer interface with an irregular border, followed later by obvious bridging ossification between the two host endplates at fusion maturation. This process was more pronounced in the one patient in whom rhBMP-2 was added to the four fusion cages. In addition, in our small series of patients, bioabsorbable cages with an anterior metallic cervical plate were able adequately to maintain anterior column height and sagittal alignment.
The clear advantage of a bioabsorbable implant in this application is the lack of an imaging artifact and the implant's progressive resorption, which leaves behind only bone at the fusion site. Theoretically, as the implant degrades over time, a greater amount of stress is transferred to the surrounding bone, which stimulates greater bone remodeling. In addition, the modulus of elasticity of these implants is closer to native bone than the stiffer metallic implants, which lessens the risks of implant migration or subsidence.
CONCLUSIONS
In this investigation the use of bioabsorbable cages was shown to allow fusion of a decompressed cervical spinal motion segment. There were no appreciable complications specifically related to implant resorption, such as a clinically relevant inflammatory response. This technology will require further prospective study of its use as a carrier for bone graft substitutes to determine whether optimal healing characteristics may eliminate the need for autogenous bone grafting and adjunctive anterior plate fixation.
Disclosure
Dr.Vaccaro was a consultant for Medtronic Sofamor Danek during the preparation of this manuscript.
The device reported in this series is not approved by the Food and Drug Administration for use in the spine. This device has been cleared by the Food and Drug Administration, however, to maintain the relative position of weak bone tissue in trauma and reconstructive orthopedic procedures when used in conjunction with traditional rigid fixation. 
